Junichi Ohtawa

486 total citations
18 papers, 378 citations indexed

About

Junichi Ohtawa is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Junichi Ohtawa has authored 18 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 15 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology and Allergy. Recurrent topics in Junichi Ohtawa's work include Asthma and respiratory diseases (18 papers), Respiratory and Cough-Related Research (11 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Junichi Ohtawa is often cited by papers focused on Asthma and respiratory diseases (18 papers), Respiratory and Cough-Related Research (11 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Junichi Ohtawa collaborates with scholars based in Japan and Australia. Junichi Ohtawa's co-authors include Makoto Hoshino and Tetsuo Satoh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical & Experimental Allergy and Annals of Allergy Asthma & Immunology.

In The Last Decade

Junichi Ohtawa

18 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junichi Ohtawa Japan 13 334 267 132 49 30 18 378
C.A. Celis-Preciado Colombia 5 173 0.5× 99 0.4× 55 0.4× 47 1.0× 11 0.4× 18 233
Sofia Necander Sweden 6 193 0.6× 131 0.5× 150 1.1× 35 0.7× 6 0.2× 18 334
Julius van Bavel United States 10 599 1.8× 283 1.1× 480 3.6× 27 0.6× 75 2.5× 16 655
Warner Carr United States 8 91 0.3× 69 0.3× 36 0.3× 24 0.5× 12 0.4× 21 145
Takao Mochimaru Japan 7 126 0.4× 91 0.3× 24 0.2× 41 0.8× 4 0.1× 12 183
Aleksandra Wardzyńska Poland 8 109 0.3× 72 0.3× 30 0.2× 32 0.7× 7 0.2× 17 156
J.L. Rodriguez-Bada Spain 7 170 0.5× 33 0.1× 250 1.9× 30 0.6× 134 4.5× 18 339
Gareth Hynes United Kingdom 6 102 0.3× 74 0.3× 14 0.1× 46 0.9× 8 0.3× 12 152
Małgorzata Olszowiec-Chlebna Poland 5 86 0.3× 56 0.2× 74 0.6× 4 0.1× 34 1.1× 10 128
María Angeles Zambonino Spain 7 155 0.5× 49 0.2× 150 1.1× 10 0.2× 111 3.7× 12 355

Countries citing papers authored by Junichi Ohtawa

Since Specialization
Citations

This map shows the geographic impact of Junichi Ohtawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichi Ohtawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichi Ohtawa more than expected).

Fields of papers citing papers by Junichi Ohtawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junichi Ohtawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichi Ohtawa. The network helps show where Junichi Ohtawa may publish in the future.

Co-authorship network of co-authors of Junichi Ohtawa

This figure shows the co-authorship network connecting the top 25 collaborators of Junichi Ohtawa. A scholar is included among the top collaborators of Junichi Ohtawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junichi Ohtawa. Junichi Ohtawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hoshino, Makoto, et al.. (2024). Long-term efficacy of house dust mite sublingual immunotherapy on clinical and pulmonary function in patients with asthma and allergic rhinitis. SHILAP Revista de lepidopterología. 3(2). 100206–100206. 6 indexed citations
2.
Hoshino, Makoto, et al.. (2022). Efficacy of a house dust mite sublingual immunotherapy tablet as add-on dupilumab in asthma with rhinitis. Allergology International. 71(4). 490–497. 22 indexed citations
3.
Hoshino, Makoto, et al.. (2020). Serum Periostin as a Biomarker for Predicting Clinical Response to House Dust Mite Sublingual Immunotherapy in Allergic Rhinitis. The Journal of Allergy and Clinical Immunology In Practice. 9(5). 1864–1870. 19 indexed citations
4.
Hoshino, Makoto, et al.. (2020). House dust mite sublingual immunotherapy reduces type 2 biomarkers in allergic asthma. 236–236. 2 indexed citations
5.
Hoshino, Makoto, et al.. (2020). Association between biomarkers and house dust mite sublingual immunotherapy in allergic asthma. Clinical & Experimental Allergy. 50(9). 1035–1043. 19 indexed citations
7.
Hoshino, Makoto, et al.. (2017). Effect of the addition of montelukast on airway inflammation and remodeling in symptomatic asthma. PA4680–PA4680. 3 indexed citations
8.
Hoshino, Makoto, et al.. (2016). Effects of the addition of tiotropium on airway dimensions in symptomatic asthma. Allergy and Asthma Proceedings. 37(6). 147–153. 23 indexed citations
9.
Hoshino, Makoto, et al.. (2016). Association of airway wall thickness with serum periostin in steroid-naive asthma. Allergy and Asthma Proceedings. 37(3). 225–230. 12 indexed citations
10.
Hoshino, Makoto, et al.. (2016). Relationship between serum periostin and airway wall thickness in asthma. PA567–PA567. 2 indexed citations
11.
Hoshino, Makoto, et al.. (2015). Effect of treatment with inhaled corticosteroid on serum periostin levels in asthma. Respirology. 21(2). 297–303. 43 indexed citations
12.
Hoshino, Makoto, et al.. (2014). Increased C-reactive protein is associated with airway wall thickness in steroid-naive asthma. Annals of Allergy Asthma & Immunology. 113(1). 37–41. 13 indexed citations
13.
Hoshino, Makoto, et al.. (2014). Comparison of airway dimensions with once daily tiotropium plus indacaterol versus twice daily Advair® in chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics. 30. 128–133. 18 indexed citations
14.
Hoshino, Makoto & Junichi Ohtawa. (2014). Computed tomography assessment of airway dimensions with combined tiotropium and indacaterol therapy in COPD patients. Respirology. 19(3). 403–410. 12 indexed citations
15.
Hoshino, Makoto & Junichi Ohtawa. (2013). Effects of Tiotropium and Salmeterol/Fluticasone Propionate on Airway Wall Thickness in Chronic Obstructive Pulmonary Disease. Respiration. 86(4). 280–287. 18 indexed citations
16.
Hoshino, Makoto & Junichi Ohtawa. (2012). Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma. Respirology. 17(4). 639–646. 15 indexed citations
17.
Hoshino, Makoto & Junichi Ohtawa. (2012). Effects of Adding Omalizumab, an Anti-Immunoglobulin E Antibody, on Airway Wall Thickening in Asthma. Respiration. 83(6). 520–528. 122 indexed citations
18.
Hoshino, Makoto & Junichi Ohtawa. (2010). Effects of adding salmeterol/fluticasone propionate to tiotropium on airway dimensions in patients with chronic obstructive pulmonary disease. Respirology. 16(1). 95–101. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026